Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Market cap
$1.7B
105M shares
52-week range
$13.73 – $16.07
100% from low
Exchange
NYSE
FUND
Borrow rate
1.11%
Moderate
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $128.6M | $124.0M | −$320.4M | $206.9M | $197.7M | $225.0M |
| Cost of revenue | $0 | $0 | $0 | $0 | $0 | $1.4M |
| Gross profit | $128.6M | $124.0M | −$320.4M | $206.9M | $197.7M | $223.6M |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 99.4% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | $128.4M | $121.3M | −$319.6M | $204.7M | $194.4M | $222.0M |
| EBITDA | $0 | $0 | −$639.0M | $411.0M | $0 | $222.0M |
| Net income | $128.4M | $121.3M | −$322.5M | $204.7M | $194.4M | $222.0M |
| Net margin | 99.9% | 97.8% | 100.7% | 98.9% | 98.4% | 98.7% |
| EPS (diluted) | 1.15 | 1.10 | -2.81 | 1.78 | 1.83 | 2.09 |
Annual figures · source: Financial Modeling Prep
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| BCATBlackRock Capital Allocation Trust | $16.07 | +1.58% | $1.7B | — |
| BDJBlackRock Enhanced Equity Dividend Trust | $9.55 | +1.60% | $1.7B | — |
| BMEZBlackRock Health Sciences Term Trust | $15.33 | +1.32% | $1.6B | — |
| BSTBlackRock Science and Technology Trust | $49.06 | +2.17% | $1.7B | — |
| BTTBlackrock Municipal 2030 Target Term Trust | $22.63 |
BlackRock Capital Allocation Trust is a non-diversified, closed-end management investment company. The investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation.
www.blackrock.comNo one on the platform currently holds BCAT.
No tracked institution reports a position in BCAT as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-09-15 | $0.2542 | 2026-09-30 |
| 2026-08-14 | $0.2542 | 2026-08-31 |
| 2026-07-15 | $0.2542 | 2026-07-31 |
| 2026-06-15 | $0.2579 | 2026-06-30 |
| 2026-05-15 | $0.2579 | 2026-05-29 |
| 2026-04-15 | $0.2579 | 2026-04-30 |
| 2026-03-13 | $0.2607 | 2026-03-31 |
| 2026-02-13 | $0.2607 | 2026-02-27 |
| 2026-01-20 | $0.2607 | 2026-01-30 |
| 2025-12-22 | $0.2620 | 2025-12-31 |
No one on the platform has traded BCAT yet.
| +0.09% |
| $1.4B |
| — |
| CIPNXChamplain Small Company Fund Institutional Class | $18.85 | -0.42% | $1.5B | — |
| ECATBlackRock ESG Capital Allocation Trust | $15.64 | +2.16% | $1.6B | — |
Source: Financial Modeling Prep · peers by sector/industry
| 2025-11-14 |
| $0.2649 |
| 2025-11-28 |
| 2025-10-15 | $0.2675 | 2025-10-31 |
$BCAT imagine paying a premium for this. I can’t wait for the rights offering
View on StockTwits ↗$BCAT add to short. This keeps trading at premium BlackRock would be fools not to do a rights offering.
View on StockTwits ↗$DVLT Day traders, swing traders, profit takers are reasons to be diversified. $BCAT $GOF $ECAT Monthly dividend ETF. Generate income while waiting on moonshots.
View on StockTwits ↗$BCAT short before they announce rights offering
View on StockTwits ↗$PDI Wonder what’s going on with this? It keeps going lower, while $BCAT seems to go up everyday.
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.
Trading at 7.7× earnings vs its 8.5× historical median P/E.
Fair value ≈ $17.85 · price $16.07 today
Fair-value line = the stock's median historical P/E × earnings. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.